Successful implementation of technology in the management of Parkinson's disease: Barriers and facilitators

IF 1.9 Q3 CLINICAL NEUROLOGY Clinical Parkinsonism Related Disorders Pub Date : 2023-01-01 DOI:10.1016/j.prdoa.2023.100188
Arjonne Laar , Ana Ligia Silva de Lima , Bart R. Maas , Bastiaan R. Bloem , Nienke M. de Vries
{"title":"Successful implementation of technology in the management of Parkinson's disease: Barriers and facilitators","authors":"Arjonne Laar ,&nbsp;Ana Ligia Silva de Lima ,&nbsp;Bart R. Maas ,&nbsp;Bastiaan R. Bloem ,&nbsp;Nienke M. de Vries","doi":"10.1016/j.prdoa.2023.100188","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Parkinson’s disease (PD) is a progressive neurodegenerative disease with a fast increasing prevalence. Several pharmacological and non-pharmacological interventions are available to alleviate symptoms. Technology can be used to improve the efficiency, accessibility and feasibility of these treatments. Although many technologies are available, only few are actually implemented in daily clinical practice.</p></div><div><h3>Aim</h3><p>Here, we study the barriers and facilitators, as experienced by patients, caregivers and/or healthcare providers, to successful implement technology for PD management.</p></div><div><h3>Methods</h3><p>We performed a systematic literature search in the PubMed and Embase databases until June 2022. Two independent raters screened the titles, abstracts and full texts on: 1) people with PD; 2) using technology for disease management; 3) qualitative research methods providing patients’, caregivers and/or healthcare providers’ perspective, and; 4) full text available in English or Dutch. Case studies, reviews and conference abstracts were excluded.</p></div><div><h3>Results</h3><p>We found 5420 unique articles of which 34 were included in this study. Five categories were made: cueing (n = 3), exergaming (n = 3), remote monitoring using wearable sensors (n = 10), telerehabilitation (n = 8) and remote consultation (n = 10). The main barriers reported across categories were unfamiliarity with technology, high costs, technical issues and (motor) symptoms hampering the use of some technologies. Facilitators included good usability, experiencing beneficial effects and feeling safe whilst using the technology.</p></div><div><h3>Conclusion</h3><p>Although only few articles presented a qualitative evaluation of technologies, we found some important barriers and facilitators that may help to bridge the gap between the fast developing technological world and actual implementation in day-to-day living with PD.</p></div>","PeriodicalId":33691,"journal":{"name":"Clinical Parkinsonism Related Disorders","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972397/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Parkinsonism Related Disorders","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590112523000063","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Background

Parkinson’s disease (PD) is a progressive neurodegenerative disease with a fast increasing prevalence. Several pharmacological and non-pharmacological interventions are available to alleviate symptoms. Technology can be used to improve the efficiency, accessibility and feasibility of these treatments. Although many technologies are available, only few are actually implemented in daily clinical practice.

Aim

Here, we study the barriers and facilitators, as experienced by patients, caregivers and/or healthcare providers, to successful implement technology for PD management.

Methods

We performed a systematic literature search in the PubMed and Embase databases until June 2022. Two independent raters screened the titles, abstracts and full texts on: 1) people with PD; 2) using technology for disease management; 3) qualitative research methods providing patients’, caregivers and/or healthcare providers’ perspective, and; 4) full text available in English or Dutch. Case studies, reviews and conference abstracts were excluded.

Results

We found 5420 unique articles of which 34 were included in this study. Five categories were made: cueing (n = 3), exergaming (n = 3), remote monitoring using wearable sensors (n = 10), telerehabilitation (n = 8) and remote consultation (n = 10). The main barriers reported across categories were unfamiliarity with technology, high costs, technical issues and (motor) symptoms hampering the use of some technologies. Facilitators included good usability, experiencing beneficial effects and feeling safe whilst using the technology.

Conclusion

Although only few articles presented a qualitative evaluation of technologies, we found some important barriers and facilitators that may help to bridge the gap between the fast developing technological world and actual implementation in day-to-day living with PD.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
技术在帕金森病管理中的成功实施:障碍和促进因素
背景帕金森病(PD)是一种进展性神经退行性疾病,发病率迅速上升。有几种药物和非药物干预措施可用于缓解症状。技术可以用来提高这些治疗的效率、可及性和可行性。尽管有许多技术可用,但在日常临床实践中实际应用的技术很少。目的在这里,我们研究了患者、护理人员和/或医疗保健提供者在成功实施PD管理技术方面遇到的障碍和促进者。方法我们在PubMed和Embase数据库中进行了系统的文献检索,直到2022年6月。两位独立的评分者对标题、摘要和全文进行了筛选:1)帕金森病患者;2) 利用疾病管理技术;3) 提供患者、护理人员和/或医疗保健提供者观点的定性研究方法;4) 全文可用英文或荷兰语。排除了案例研究、综述和会议摘要。结果共发现5420篇独特的文章,其中34篇被纳入本研究。分为五类:提示(n=3)、运动游戏(n=3。各类别报告的主要障碍是对技术不熟悉、成本高、技术问题和阻碍某些技术使用的(电机)症状。促进者包括良好的可用性、体验有益的效果以及在使用该技术时感到安全。结论尽管只有少数文章对技术进行了定性评估,但我们发现了一些重要的障碍和促进因素,这些障碍和促进因子可能有助于弥合快速发展的技术世界与PD日常生活中的实际实施之间的差距。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Parkinsonism  Related Disorders
Clinical Parkinsonism Related Disorders Medicine-Neurology (clinical)
CiteScore
2.70
自引率
0.00%
发文量
50
审稿时长
98 days
期刊最新文献
Meaning in life and Parkinson’s disease in the UK Biobank Validation of the Kazakh version of the movement disorder Society-Unified Parkinson's disease rating scale Movement disorder Deep brain stimulation Hybridization: Patient and caregiver outcomes Impulse control and related behavioral disorders (ICRD) in Idiopathic Parkinson’s Disease treated with different dopamine agonists in Hong Kong: Is any dopamine agonist better? Overview of management of infection-related movement disorders with focus on specific-infections
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1